MarginsXMarginsX
Home › Markets › Health Care › PEN

Penumbra Inc. (PEN)

PEN trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$320.62
-0.09% on the day
Market cap
$12.6B
Large cap
Revenue · 2025
$1.4B
+17.5% on 2024
Net income · 2025
$177.7M
12.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1321732/000132173226000007/0001321732-26-000007-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerPEN on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2015
SEC CIK0001321732
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.4B
Net income$177.7M
Operating income$189.2M
Net margin12.7%
Operating margin13.5%
Revenue growth+17.5%
Cash$186.9M
Total assets$1.8B
P/E (computed)71.1×
P/S (computed)9.0×

Warning signs

Cash runway
Cash-flow positive
$254.3M cash at September 30, 2026
Share count, 1 year
+0.6%
2025-10-22 to 2026-10-14 · +2.1% over 3 years
Going-concern doubt
No
10-Q filed October 29, 2026
Insider net buying, 12 months
-$11.3M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-29
Cash and burn$254.3M cash; operating cash flow $65.3M a quarter.Report 2026-09-30
Shares outstanding39,414,385 (2026-10-14); 39,162,177 a year earlier; 38,596,366 three years earlier.Cover page 2026-10-14
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, San Jose, California, United StatesPCAOB Form AP 2026-03-17
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $11.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$410.1M$42.3M$41.5M$254.3MNo debt tags$1.6B10-Q 2026-10-29
Q2 2026
2026-06-30
$390.0M$34.8M$46.1M$205.3MNo debt tags$1.5B10-Q 2026-07-30
Q1 2026
2026-03-31
$374.8M$32.6M$87.0M$241.3MNo debt tags$1.5B10-Q 2026-05-06
Q4 2025
2025-12-31
$385.4M$47.3M$86.5M$186.9MNo debt tags$1.4B10-K 2026-02-25
Q3 2025
2025-09-30
$354.7M$45.9M$58.3M$321.0MNo debt tags$1.3B10-Q 2026-10-29
Q2 2025
2025-06-30
$339.5M$45.3M$44.9M$421.8MNo debt tags$1.3B10-Q 2026-07-30
Q1 2025
2025-03-31
$324.1M$39.2M$49.0M$376.1MNo debt tags$1.2B10-Q 2026-05-06
Q4 2024
2024-12-31
$315.5M$33.7M$51.1M$324.4MNo debt tags$1.2B10-K 2026-02-25

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2023-02-23
Latest annual report10-K2026-02-25
Latest quarterly / interim10-Q2026-10-29
Latest current report8-K2026-10-29
Latest proxyDEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 956 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.5%
1 month+0.3%
3 months-1.8%
Year to date+3.2%
1 year+15.1%
From 52-week high-10.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
BAXBaxter International Inc.$25.54-1.05%$13.2B
GKOSGlaukos Corporation$244.88-0.34%$14.5B
SOLVSolventum Corporation$88.65-0.48%$15.0B
PODDInsulet Corporation$145.29-4.72%$10.1B
GMEDGlobus Medical Inc.$70.50-2.27%$9.3B
TFXTeleflex Incorporated$157.10+1.51%$6.2B
HAEHaemonetics Corporation$121.34-1.30%$5.5B
WSTWest Pharmaceutical Services Inc.$417.80+0.33%$29.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier